Imunon, Inc. Common Stock Shares Outstanding

• Imunon, Inc. showed an increase of +22,797,566.7% in Common Stock Shares Outstanding from 2025 to 2025.
• This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 20 years of available data (2010 to 2025), Imunon, Inc.'s Common Stock Shares Outstanding has declined by 74.3%.
• Historical annual values: Fiscal year 2025: 3.42 million shares | Fiscal year 2025: 15 shares | Fiscal year 2024: 966,712 shares | Fiscal year 2023: 9.40 million shares | Fiscal year 2022: 7.44 million shares | Fiscal year 2022: 86.56 million shares | Fiscal year 2021: 5.77 million shares | Fiscal year 2020: 2.71 million shares | Fiscal year 2019: 23.26 million shares | Fiscal year 2018: 18.83 million shares | Fiscal year 2017: 17.28 million shares | Fiscal year 2017: 4.07 million shares | Fiscal year 2016: 2.23 million shares | Fiscal year 2015: 23.32 million shares | Fiscal year 2014: 19.98 million shares | Fiscal year 2013: 13.60 million shares | Fiscal year 2013: 13.60 million shares | Fiscal year 2012: 8.29 million shares | Fiscal year 2011: 33.19 million shares | Fiscal year 2010: 13.33 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026